Index RUT
P/E -
EPS (ttm) -0.50
Insider Own 17.44%
Shs Outstand 43.67M
Perf Week 2.71%
Market Cap 553.01M
Forward P/E -
EPS next Y -0.30
Insider Trans 0.24%
Shs Float 36.23M
Perf Month -26.90%
Income -21.67M
PEG -
EPS next Q -0.11
Inst Own 55.64%
Short Float 10.45%
Perf Quarter -29.95%
Sales 84.50M
P/S 6.54
EPS this Y 11.10%
Inst Trans -3.46%
Short Ratio 10.46
Perf Half Y 99.41%
Book/sh 2.26
P/B 5.57
EPS next Y 30.85%
ROA -16.62%
Short Interest 3.79M
Perf Year 52.95%
Cash/sh 1.73
P/C 7.30
EPS next 5Y -
ROE -20.93%
52W Range 4.60 - 20.90
Perf YTD 84.79%
Dividend Est. -
P/FCF -
EPS past 5Y 20.06%
ROI -21.78%
52W High -39.70%
Beta 0.66
Dividend TTM -
Quick Ratio 5.67
Sales past 5Y 37.03%
Gross Margin 86.41%
52W Low 173.97%
ATR (14) 0.84
Dividend Ex-Date -
Current Ratio 6.15
EPS Y/Y TTM 70.66%
Oper. Margin -29.68%
RSI (14) 45.40
Volatility 5.16% 6.82%
Employees 100
Debt/Eq 0.01
Sales Y/Y TTM 12.62%
Profit Margin -25.64%
Recom 1.86
Target Price 21.14
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q -3.49%
Payout -
Rel Volume 0.37
Prev Close 12.02
Sales Surprise -12.50%
EPS Surprise -10.29%
Sales Q/Q -1.58%
Earnings May 07 AMC
Avg Volume 362.05K
Price 12.60
SMA20 0.79%
SMA50 -11.17%
SMA200 26.53%
Trades
Volume 87,232
Change 4.85%
Date
Action
Analyst
Rating Change
Price Target Change
May-10-23 Upgrade
Wedbush
Neutral → Outperform
$5 → $13
Apr-03-23 Downgrade
Guggenheim
Buy → Neutral
Jan-27-23 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$4
Jan-05-23 Downgrade
Cowen
Outperform → Market Perform
Dec-02-22 Downgrade
BofA Securities
Buy → Neutral
$23 → $5
Dec-02-22 Downgrade
BofA Securities
Buy → Neutral
Oct-31-22 Downgrade
Wedbush
Outperform → Neutral
$6
Oct-31-22 Downgrade
JP Morgan
Neutral → Underweight
$16 → $7
Jul-06-22 Resumed
Canaccord Genuity
Buy
$35
Jun-24-22 Initiated
BMO Capital Markets
Outperform
$27
Feb-03-22 Resumed
Guggenheim
Buy
$22
Nov-19-21 Resumed
Morgan Stanley
Equal-Weight
$25
Nov-16-21 Downgrade
JP Morgan
Overweight → Neutral
$57 → $30
May-07-21 Upgrade
BofA Securities
Neutral → Buy
Apr-23-21 Resumed
Cowen
Outperform
Mar-22-21 Resumed
JP Morgan
Overweight
$57 → $52
Jan-15-21 Downgrade
BofA Securities
Buy → Neutral
$56
Nov-09-20 Reiterated
H.C. Wainwright
Buy
$52 → $65
May-05-20 Initiated
Barclays
Overweight
$44
May-01-20 Initiated
Janney
Buy
Show Previous Ratings
Today 07:05AM
Jun-01-24 08:15AM
08:05AM
May-09-24 11:58AM
03:04AM
09:57PM
Loading…
May-08-24 09:57PM
(Thomson Reuters StreetEvents) -20.92%
May-07-24 09:55PM
06:12PM
05:55PM
04:05PM
Apr-26-24 07:05AM
Apr-25-24 04:05PM
Mar-28-24 09:55AM
Mar-20-24 07:37AM
Mar-14-24 09:05AM
09:55AM
Loading…
Mar-12-24 09:55AM
Mar-05-24 12:00PM
Mar-04-24 08:45AM
07:30AM
Mar-01-24 09:42PM
(Thomson Reuters StreetEvents) +11.92%
Feb-29-24 05:25PM
04:37PM
04:05PM
Feb-22-24 10:00AM
Feb-16-24 07:30AM
Feb-13-24 04:10AM
Jan-02-24 04:05PM
Dec-13-23 04:05PM
Dec-12-23 01:05AM
Dec-03-23 03:04AM
11:04PM
Loading…
Nov-30-23 11:04PM
Nov-15-23 01:14PM
01:33AM
(Thomson Reuters StreetEvents)
Nov-13-23 05:31PM
05:25PM
04:05PM
Nov-08-23 12:00PM
Oct-31-23 07:05AM
Oct-18-23 04:05PM
Oct-17-23 04:05PM
Oct-16-23 04:05PM
Sep-21-23 04:05PM
Sep-06-23 04:05PM
Aug-23-23 09:55AM
Aug-13-23 06:25AM
Aug-10-23 05:15PM
04:05PM
Aug-02-23 04:05PM
Aug-01-23 04:05PM
Jul-26-23 12:35PM
Jun-02-23 03:15PM
May-26-23 09:00AM
09:00AM
May-23-23 09:00AM
May-18-23 06:39AM
May-13-23 08:18AM
May-10-23 06:14AM
02:52AM
(Thomson Reuters StreetEvents)
May-08-23 05:15PM
04:01PM
May-01-23 10:01AM
Apr-28-23 09:00AM
Apr-18-23 09:00AM
Apr-17-23 10:57AM
Apr-05-23 07:44PM
09:55AM
09:00AM
Apr-04-23 05:12AM
Mar-30-23 05:25PM
04:01PM
02:42PM
Mar-21-23 04:01PM
Mar-15-23 10:22AM
Feb-20-23 10:00AM
Feb-16-23 10:01AM
07:57AM
Feb-02-23 09:00AM
Jan-05-23 10:34AM
Jan-04-23 04:01PM
Jan-03-23 09:00AM
Dec-21-22 09:00AM
Dec-16-22 04:01PM
Dec-14-22 09:00AM
Dec-08-22 09:00AM
Dec-07-22 09:19AM
Dec-06-22 09:00AM
Dec-01-22 05:34PM
Nov-07-22 05:15PM
04:01PM
Nov-02-22 04:01PM
Oct-31-22 03:01PM
08:52AM
05:34AM
Oct-28-22 03:33PM
Oct-06-22 09:34AM
Oct-03-22 09:00AM
Sep-29-22 02:53AM
Sep-26-22 09:00AM
Sep-09-22 08:35AM
Sep-01-22 04:05PM
Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kruse Bo EVP, CFO, SECRY & TREAS. May 31 '24 Option Exercise 2.00 31,371 62,742 242,248 May 31 09:36 PM Kruse Bo EVP, CFO, SECRY & TREAS. May 31 '24 Sale 12.07 31,371 378,648 210,877 May 31 09:36 PM Kruse Bo EVP, CFO, SECRY & TREAS. May 30 '24 Option Exercise 2.00 28,629 57,258 239,506 May 31 09:36 PM Kruse Bo EVP, CFO, SECRY & TREAS. May 30 '24 Sale 12.03 28,629 344,407 210,877 May 31 09:36 PM Gad Thomas CHIEF BUSINESS OFFICER May 23 '24 Sale 13.00 7,351 95,563 232,681 May 23 06:54 PM Gad Thomas CHIEF BUSINESS OFFICER May 21 '24 Sale 12.00 25,000 300,000 240,032 May 23 06:54 PM Gad Thomas CHIEF BUSINESS OFFICER Mar 05 '24 Sale 16.44 3,900 64,116 158,700 Mar 07 05:01 PM Rajah Vignesh SVP & CHIEF MEDICAL OFFICER Mar 05 '24 Sale 16.53 1,711 28,283 33,889 Mar 07 05:02 PM Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER Mar 05 '24 Sale 16.55 1,682 27,837 33,918 Mar 07 04:59 PM Gad Thomas Chief Business Officer Dec 21 '23 Option Exercise 2.00 50,000 100,000 140,500 Dec 26 04:15 PM Gad Thomas Chief Business Officer Dec 15 '23 Sale 6.61 50,000 330,500 265,032 Dec 15 07:40 PM Gad Thomas Chief Business Officer Dec 14 '23 Sale 6.83 50,000 341,500 315,032 Dec 15 07:40 PM Gad Thomas Chief Business Officer Dec 13 '23 Sale 6.58 50,000 329,000 365,032 Dec 15 07:40 PM WG Biotech ApS Director Dec 11 '23 Buy 7.01 102,863 720,843 4,552,778 Dec 11 05:25 PM Wedell-Wedellsborg Johan Director Dec 11 '23 Buy 7.01 102,863 720,843 4,552,778 Dec 11 05:25 PM Wedell-Wedellsborg Johan Director Dec 11 '23 Buy 6.85 6,455 44,232 4,559,233 Dec 12 08:26 AM WG Biotech ApS Director Dec 11 '23 Buy 6.85 6,455 44,232 4,559,233 Dec 12 08:27 AM WG Biotech ApS Director Dec 08 '23 Buy 6.99 18,503 129,379 4,449,915 Dec 11 05:25 PM Wedell-Wedellsborg Johan Director Dec 08 '23 Buy 6.99 18,503 129,379 4,449,915 Dec 11 05:25 PM Wedell-Wedellsborg Johan Director Dec 07 '23 Buy 6.50 6,183 40,190 4,431,412 Dec 11 05:25 PM WG Biotech ApS Director Dec 07 '23 Buy 6.50 6,183 40,190 4,431,412 Dec 11 05:25 PM Wedell-Wedellsborg Johan Director Nov 29 '23 Buy 5.97 51,837 309,477 4,425,229 Dec 01 05:14 PM WG Biotech ApS Director Nov 29 '23 Buy 5.97 51,837 309,477 4,425,229 Dec 01 05:15 PM WG Biotech ApS Director Nov 28 '23 Buy 5.81 30,671 178,275 4,373,392 Nov 29 05:14 PM Wedell-Wedellsborg Johan Director Nov 28 '23 Buy 5.81 30,671 178,275 4,373,392 Nov 29 05:15 PM Wedell-Wedellsborg Johan Director Nov 27 '23 Buy 5.49 62,516 343,019 4,342,721 Nov 29 05:15 PM WG Biotech ApS Director Nov 27 '23 Buy 5.49 62,516 343,019 4,342,721 Nov 29 05:14 PM Gad Thomas Chief Business Officer Nov 21 '23 Sale 5.31 75,000 397,988 415,032 Nov 22 05:00 PM Gad Thomas Chief Business Officer Nov 20 '23 Sale 5.30 75,000 397,395 490,032 Nov 22 05:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite